Biogen Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Biogen Inc. (BIIB) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
UnitedHealth Group Incorporated narrowly edges Biogen Inc. on Q·Score (7.1 vs 6.4 out of 10), led by Growth (7.5 vs 5.3) and Valuation (8.1 vs 6.4). Biogen Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for UNH (+25.4%) than for BIIB (+9.2%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ low return on equity (5%).
85% of 27 covering analysts have a positive rating.
Analyst Consensus
Fundamentals
Frequently Asked Questions
BIIB vs UNH: which stock scores better overall?
Based on Q·Score, UnitedHealth Group Incorporated (UNH) scores 7.1/10 versus Biogen Inc. (BIIB) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: BIIB or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Growth (7.5/10 vs 5.3/10). Biogen Inc. reports revenue growth (3.4% YoY) while UnitedHealth Group Incorporated reports (0.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is BIIB or UNH more attractively valued?
UnitedHealth Group Incorporated (UNH) scores higher on Valuation (8.1/10 vs 6.4/10). BIIB trades at 13.1× P/E versus UNH at 16.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about BIIB vs UNH?
There are 31 analysts covering BIIB with a consensus price target of $237.19, and 26 analysts covering UNH with a consensus target of $475.23. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: BIIB or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Quality (6.2/10 vs 4.7/10). Net profit margin: BIIB at 8.3%, UNH at 3.1%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: BIIB or UNH?
Biogen Inc. (BIIB) scores higher on Financial Health (9.1/10 vs 5.8/10). Market beta: BIIB at 0.17, UNH at 0.62. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of BIIB and UNH?
Biogen Inc. (BIIB) has a market capitalisation of $32.1B, while UnitedHealth Group Incorporated (UNH) has a market cap of $340.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do BIIB or UNH pay dividends?
BIIB does not currently pay a dividend, while UNH pays a dividend yield of 2.45%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →